Genetic Susceptibility To Late Normal Tissue Injury

Seminars in Radiation Oncology

Volumn 17, Issue 2, 2007, Pages 149-155

  Travis, Elizabeth L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

APEX GENE; ARTICLE; ATM GENE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; FIBROSIS; GENE; GENE EXPRESSION PROFILING; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HUMAN; LINKAGE ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; QUANTITATIVE TRAIT LOCUS; RADIATION EXPOSURE; RADIATION INJURY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOD2 GENE; SURVIVAL TIME; XRCC3 GENE;

ANIMALS; FIBROSIS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, INBRED STRAINS; RADIATION INJURIES; RADIOTHERAPY; TRANSFORMING GROWTH FACTOR BETA;

EID: 33947503734     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.11.011     Document Type: Article

References (83)

1. Yabroff K.R., Lawrence W.F., Clauser S., et al. Burden of illness in cancer survivors: Findings from a population-based national sample. J Natl Cancer Inst 96 (2004) 1322-1330
2. Aziz N.M., and Rowland J.H. Trends and advances in cancer survivorship research: Challenge and opportunity. Semin Radiat Oncol 13 (2003) 248-266
3. Gauldie J. Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165 (2002) 1205-1206
4. Strieter R.M. Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165 (2002) 1206-1207
5. Turreson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19 (1990) 1569-1574
6. Safwat A., Bentzen S.M., Turesson I., et al. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys 52 (2002) 198-204
7. Abadir R., and Hakami N. Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy doses. Br J Radiol 56 (1983) 343-345
8. Alter B.P. Radiosensitivity in Fanconi's anemia patients. Radiother Oncol 62 (2002) 345-347
9. Gatti R.A. The inherited basis of human radiosensitivity. Acta Oncol 40 (2001) 702-711
10. Taylor A.M.R., Harnden D.G., Arlett C.F., et al. Ataxia telangiectasia: A human mutation with abnormal radiation sensitivity. Nature 258 (1975) 427-429
11. Hart R.M., Kimler B.F., Evans R.G., et al. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys 13 (1987) 1237-1240
12. Geara F.B., Peters L.J., Ang K.K., Wike J., et al. Radiosensitivity measurement of keratinocytes and fibroblasts from radiotherapy patients. Int J Radiat Oncol Biol Phys 24 (1992) 287-293
13. Haston C.K., and Travis E.L. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res 57 (1997) 5286-5291
14. Franko A.J., Sharplin J., Ward W.F., et al. The genetic basis of strain-dependent differences in the early phase of radiation injury in mouse lung. Radiat Res 126 (1991) 349-356
15. Franko A.J., Sharplin J., Ward W.F., et al. Evidence for two patterns of inheritance of sensitivity to induction of lung fibrosis in mice by radiation, one of which involves two genes. Radiat Res 146 (1996) 68-74
16. Haston C.K., Zhou X., Gumbiner-Russo L., et al. Universal and radiation-specific loci influence murine susceptibility to radiation-induced pulmonary fibrosis. Cancer Res 62 (2002) 3782-3788
17. Haston C.K., Tomko T.G., Godin N., et al. Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. J Med Genet 42 (2005) 464-473
18. Haston C.K., Amos C.I., King T.M., et al. Inheritance of susceptibility to bleomycin-induced pulmonary fibrosis in the mouse. Cancer Res 56 (1996) 2596-2601
19. Haston C.K., Wang M., Dejournett R.E., et al. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet 11 (2002) 1855-1863
20. Kleeberger S.R. Genetic susceptibility to ozone exposure. Toxicol Lett 82-83 (1995) 295-300
21. Kleeberger S.R., Bassett D.J.P., Jakab G.J., et al. A genetic model for evaluation of susceptibility to ozone-induced inflammation. Am J Physiol 264 (1990) L313-L320
22. Kleeberger S.R., Levitt R.C., and Zhang L.Y. Susceptibility to ozone-induced inflammation. II. Separate loci control responses to acute and subacute exposures. Am J Physiol 264 (1993) L21-L26
23. Kleeberger S.R., Levitt R.C., and Zhang L.Y. Susceptibility to ozone-induced inflammation. I. Genetic control of the response to subacute exposure. Am J Physiol 264 (1993) L15-L20
24. Kleeberger S.R., Levitt R.C., Zhang L.Y., et al. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice (Letter). Nat Genet 17 (1997) 475-478
25. Kleeberger S.R. Genetic aspects of susceptibility to air pollution. Eur Respir J Suppl 40 (2003) 52s-56s
26. Kleeberger S.R. Genetic aspects of pulmonary responses to inhaled pollutants. Exp Toxicol Pathol 57 suppl 1 (2005) 147-153
27. Frankel W.N. Taking stock of complex trait genetics in mice. Trends Genet 11 (1995) 471-477
28. Lindblad-Toh K., Winchester E., Daly M.J., et al. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet 24 (2000) 381-386
29. Sharplin J., and Franko A.J. Quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the early phase. Radiat Res 119 (1989) 1-14
30. Johnston C.J., Piedboeuf B., Rubin P., Williams J.P., Baggs R., and Finkelstein J.N. Early and persistent alterations in the expression of interleukin-1a, interleukin01b and tumor necrosis factor a mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res 145 (1996) 762-767
31. Johnston C.J., Williams J.P., Okunieff P., et al. Radiation-induced pulmonary fibrosis: Examination of chemokine and chemokine receptor families. Radiat Res 157 (2002) 256-265
32. Johnston C.J., Wright T.W., Rubin P., et al. Alterations in the expression of chemokine mRNA levels in fibrosis-resistant and -sensitive mice after thoracic irradiation. Exp Lung Res 24 (1998) 321-337
33. Kolb M., Bonniaud P., Galt T., et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol 27 (2002) 141-150
34. Du M., Irani R., Stivers D.N., et al. H2 ea deficiency is a risk factor for bleomycin induced lung fibrosis in mice. Cancer Res 64 (2004) 6835-6839
35. Nadeau J.H., Singer J.B., Matin A., et al. Analysing complex genetic traits with chromosome substitution strains. Nat Genet 24 (2000) 221-225
36. Wills-Karp M., and Ewart S.L. Time to draw breath: Asthma-susceptibility genes are identified. Nat Rev Genet 5 (2004) 376-387
37. Karp C.L., Grupe A., Schadt E., et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 1 (2000) 221-226
38. Eaves I.A., Wicker L.S., Ghandour G., et al. Combining mouse congenic strains and microarray gene expression analysis to study a complex trait: The NOD model of type 1 diabetes. Genome Res 12 (2002) 232-243
39. Rikke B.A., and Johnson T.E. Towards the cloning of genes underlying murine QTLs. Mamm Genome 9 (1998) 963-968
40. Sheppard D. Uses of expression microarrays in studies of pulmonary fibrosis, asthma, acute lung injury, and emphysema. Chest 121 (2002) 21S-25S
41. Sandford A., Weir T., and Pare P. The genetics of asthma. Am J Respir Crit Care Med 153 (1996) 1749-1765
42. Bauer A.K., Malkinson A.M., and Kleeberger S.R. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: Genetic similarities. Am J Physiol Lung Cell Mol Physiol 287 (2004) L685-L703
43. Selman M., Pardo A., Barrera L., et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med 173 (2006) 188-198
44. Grutters J.C., and du Bois R.M. Genetics of fibrosing lung diseases. Eur Respir J 25 (2005) 915-927
45. Kleeberger S.R., Reddy S., Zhang L.Y., et al. Genetic susceptibility to ozone-induced lung hyperpermeability: role of toll-like receptor 4. Am J Respir Cell Mol Biol 22 (2000) 620-627
46. Cho H.Y., Zhang L.Y., and Kleeberger S.R. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Am J Physiol Lung Cell Mol Physiol 280 (2001) L537-L546
47. Bitterman P.B., and Crystal R.G. Is there a fibrotic gene?. Chest 78 (1980) 549-550
48. Geara F.B., Komaki R., Tucker S.L., et al. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: Evidence for inherent interindividual variation. Int J Radiat Oncol Biol Phys 41 (1998) 279-286
49. Marshall R.P., McAnulty R.J., and Laurent G.J. The pathogenesis of pulmonary fibrosis: is there a fibrosis gene?. Int J Biochem Cell Biol 29 (1997) 107-120
50. Rossi G.A., Szapiel S., Ferrans V.J., et al. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. Am Rev Respir Dis 135 (1987) 448-455
51. Ekimoto H., Takada K., Ohnuki T., et al. Different sensitivity to bleomycin-induced pulmonary fibrosis among various strains of mice. J Clin Biochem Nutr 2 (1987) 25-31
52. Schrier D.J., Kunkel R.G., and Phan S.H. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 127 (1983) 63-66
53. Baecher-Allan C.M., and Barth R.K. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg Immunol 5 (1993) 207-217
54. Filderman A.E., and Lazo J.S. Murine strain differences in pulmonary bleomycin metabolism. Biochem Pharmacol 42 (1991) 195-198
55. Ohtsuka Y., Brunson K.J., Jedlicka A.E., et al. Genetic linkage analysis of susceptibility to particle exposure in mice. Am J Respir Cell Mol Biol 22 (2000) 574-581
56. Honda K., Kimura A., Dong R.P., et al. Immunogenetic analysis of silicosis in Japan. Am J Respir Cell Mol Biol 8 (1993) 106-111
57. Weiss R.B. Hypersensitivity reactions. Semin Oncol 19 (1992) 458-477
58. Podolin P.L., Denny P., Lord C.J., Hill N.J., et al. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J Immunol 159 (1997) 1835-1843
59. Morel L., Blenman K.R., Croker B.P., and Wakeland E.K. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A 98 (2001) 1787-1792
60. Andreassen C.N., Alsner J., and Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis-Where and how to look for it?. Radiother Oncol 64 (2002) 131-140
61. Russell N.S., and Begg A.C. Editorial radiotherapy and oncology 2002: Predictive assays for normal tissue damage. Radiother Oncol 64 (2002) 125-129
62. Holscher T., Bentzen S.M., and Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: A systematic review. Radiother Oncol 78 (2006) 123-130
63. Andreassen C.N., Alsner J., Overgaard M., et al. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69 (2003) 127-135
64. Andreassen C.N., Alsner J., Overgaard J., et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75 (2005) 18-21
65. Bentzen S.M., Dorr W., Anscher M.S., et al. Normal tissue effects: Reporting and analysis. Semin Radiat Oncol 13 (2003) 189-202
66. Bentzen S.M., and Thames H.D. Incidence and latency of radiation reactions. Radiother Oncol 14 (1989) 261-262
67. Bentzen S.M., Vaeth M., Pedersen D.E., et al. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment. Now! Int J Radiat Oncol Biol Phys 32 (1995) 1531-1534
68. Dileto C.L., and Travis E.L. Fibroblast radiosensitivity in vitro and lung fibrosis: Comparison between a fibrosing and non-fibrosing mouse strain. Radiat Res 146 (1996) 61-67
69. Ho A.Y., Atencio D.P., Peters S., et al. Genetic predictors of adverse radiotherapy effects: The Gene-PARE project. Int J Radiat Oncol Biol Phys 65 (2006) 646-655
70. West C.M., McKay M.J., Holscher T., et al. Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys 62 (2005) 1264-1273
71. Baumann M., Holscher T., and Begg A.C. Towards genetic prediction of radiation responses: ESTRO's GENEPI project. Radiother Oncol 69 (2003) 121-125
72. Anscher M.S., Crocker I.R., and Jirtle R.L. Transforming growth factor-β1 expression in irradiated liver. Radiat Res 122 (1990) 77-85
73. Anscher M.S., Peters W.P., Reisenbichler H., et al. Transforming growth factor β as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328 (1993) 1592-1598
74. Li C., Wilson P.B., Levine E., et al. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer 84 (1999) 155-159
75. Grainger D.J., Heathcote K., Chiano M., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8 (1999) 93-97
76. El-Gamel A., Awad M.R., Hasleton P.S., et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 18 (1999) 517-523
77. Awad M.R., El-Gamel A., Hasleton P., et al. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
78. El-Gamel A., Awad M., Sim E., et al. Transforming growth factor-beta1 and lung allograft fibrosis. Eur J Cardiothorac Surg 13 (1998) 424-430
79. Quarmby S., Fakhoury H., Levine E., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
80. Anscher M.S., Thrasher B., Rabbani Z., et al. Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys 65 (2006) 876-881
81. Bonniaud P., Margetts P.J., Ask K., et al. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 175 (2005) 5390-5395
82. Vallance B.A., Gunawan M.I., Hewlett B., et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol 289 (2005) G116-G128
83. Sime P.J., Xing Z., Graham F.L., et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100 (1997) 768-776